Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Results of the reference sera from the CDC and AMLI in the new anti-SmD3 peptide ELISA

From: Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies

Sample ID U/ml Sample ID U/ml Diagnosis
ANA 1 10.3 SLR Research A 2.5 CREST
ANA 2 1.4 SLR Research B 2.9 Scl
ANA 3 1.9 SLR Research D 2.8 MCTD
ANA 4 2.5 SLR Research E 3.1 SS, SLE
ANA 5 910.0 SLR Research F 1.5 PM
ANA 6 3.1 SLR Research G 4.5 SS
ANA 7 0.0 SLR Research I 1420.0 SLE
ANA 8 0.1 SLR Research J 13.9 SLE
ANA 9 1.7 SLR Research K 0.0 HD
ANA 10 0.5 SLR Research L 0.2 HD
  1. AMLI, Association of Medical Laboratory Immunologists; CDC, Center for Disease Control and Prevention; CREST, calcinosis cutis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly and telangiectasia; HD, healthy donor; MCTD, mixed connective tissue disease; PM, polymyositis; Scl, scleroderma; SLE, systemic lupus erythematosus; SS, Sjögren's syndrome.